Cargando…
The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples
SIMPLE SUMMARY: Prostate cancer is one of the most common malignancies in men. Current therapies are initially effective but resistance often develops, leading to tumor recurrence and death. Further research on new players, mechanisms involved in prostate cancer, and therapy resistance is needed. We...
Autores principales: | Stücheli, Simon, Araya, Selene, Ercan, Caner, Moser, Seraina O., Gallon, John, Jenö, Paul, Piscuoglio, Salvatore, Terracciano, Luigi, Odermatt, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264982/ https://www.ncbi.nlm.nih.gov/pubmed/35804847 http://dx.doi.org/10.3390/cancers14133074 |
Ejemplares similares
-
A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer
por: Seibert, Julia K, et al.
Publicado: (2015) -
Hypermethylation of DHRS3 as a Novel Tumor Suppressor Involved in Tumor Growth and Prognosis in Gastric Cancer
por: Sumei, Sha, et al.
Publicado: (2021) -
Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report
por: Meier, Marie-Anne, et al.
Publicado: (2022) -
Auxiliary Diagnosis and Prognostic Value of Dehydrogenase/Reductase 2 (DHRS2) in Various Tumors
por: An, Zhongwu, et al.
Publicado: (2023) -
High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall Survival
por: Lalos, Alexandros, et al.
Publicado: (2021)